View Older Stories View More Recent Stories

Dec 29, 2025 03:27PM Ultragenyx Pharma (RARE) PT Lowered to $70 at Leerink Partners

Dec 29, 2025 03:27PM Mereo BipPharma Group (MREO) PT Lowered to $2 at Leerink Partners

Dec 29, 2025 01:50PM TD Cowen Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 01:11PM LifeSci Capital Downgrades Mereo BipPharma Group (MREO) to Market Perform

Dec 29, 2025 12:48PM Ultragenyx Pharma (RARE) PT Lowered to $47 at Baird

Dec 29, 2025 12:12PM Ultragenyx Pharma (RARE) PT Lowered to $50 (from $103) at Citi

Dec 29, 2025 12:04PM William Blair Reiterates Outperform Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 12:04PM Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 12:03PM Morgan Stanley Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 12:03PM Truist Securities Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Dec 29, 2025 08:25AM Ultragenyx Pharma (RARE) halted, news pending

Nov 21, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Nov 5, 2025 09:34AM Citi Opens 90-Day Upside Catalyst Watch on Ultragenyx Pharma (RARE)

Nov 5, 2025 04:51AM Ultragenyx Pharma (RARE) PT Lowered to $72 at RBC Capital

Nov 4, 2025 04:19PM Ultragenyx Pharma (RARE) Misses Q3 EPS by 58c, provides guidance

Oct 17, 2025 05:56AM Ultragenyx Pharma (RARE) January 50 calls active

Sep 22, 2025 07:15AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Sep 9, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Aug 18, 2025 08:06AM Ultragenyx begins rolling FDA submission for GSDIa gene therapy

Jul 28, 2025 06:58AM H.C. Wainwright Assumes Ultragenyx Pharma (RARE) at Buy

Jul 14, 2025 08:01AM Health Canada approves Evkeeza for infants as young as 6 months with HoFH

Jul 14, 2025 05:08AM Ultragenyx Pharma (RARE) December options active

Jul 11, 2025 05:05PM Ultragenyx stock falls after FDA issues complete response letter for gene therapy

Jul 11, 2025 04:30PM Ultragenyx receives FDA rejection for gene therapy to treat rare disease

Jul 10, 2025 10:52AM TD Cowen: 'Ultragenyx Pharma (RARE) a Buying Oppy Ahead Of Dec '25 Readout'

Jul 10, 2025 07:49AM BTIG Reiterates Buy Rating on Mereo BipPharma Group (MREO)

Jul 10, 2025 07:43AM Morgan Stanley Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 06:44AM Canaccord Genuity Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 06:42AM Ultragenyx Pharma (RARE) PT Lowered to $65 at Wells Fargo

Jul 10, 2025 06:20AM BofA Securities on Ultragenyx Pharma (RARE): 'top 2025 pick'

Jul 10, 2025 06:01AM Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Jul 10, 2025 05:50AM Citi Opens 90d Upside Cat Call on Ultragenyx Pharma (RARE)

Jul 9, 2025 04:51PM After-hours movers: WK Kellogg, Costco, Ultragenyx Pharma

Jul 9, 2025 04:05PM Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis

Jun 27, 2025 08:00AM Ultragenyx Pharma (RARE) Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome

Jun 23, 2025 10:33AM TD Cowen's Best Smidcap Ideas 2025

May 28, 2025 05:06AM William Blair Starts Ultragenyx Pharma (RARE) at Outperform

May 6, 2025 04:48PM Ultragenyx Pharma (RARE) Misses Q1 EPS by 1c, provides guidance

Apr 22, 2025 03:22PM Ultragenyx Pharma (RARE) spreader of 1K contracts of July 30 puts, July 40 calls and July 50 calls

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 19, 2025 06:43AM Mereo and Ultragenyx remain top picks at Cantor Fitzgerald

Mar 17, 2025 08:13AM Ultragenyx Pharma (RARE) PT Lowered to $115 at Piper Sandler 'Ahead of Near-Term Value Inflection'

Feb 26, 2025 09:10AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Feb 19, 2025 07:13AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 18, 2025 08:07AM Ultragenyx Pharma (RARE) Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A

Feb 18, 2025 06:52AM Ultragenyx Pharma (RARE) PT Raised to $136 at Canaccord Genuity

Feb 14, 2025 07:16AM Cantor Fitzgerald Reiterates Overweight Rating on Ultragenyx Pharma (RARE)

Feb 14, 2025 06:57AM Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 13, 2025 08:55PM Truist Securities Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Feb 13, 2025 04:50PM Ultragenyx Pharma (RARE) Misses Q4 EPS by 5c; offers guidance

View More Recent Stories View Older Stories